![Gerry Brunk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerry Brunk
President at
LAVA MEDTECH ACQUISITION CORP.
Net worth: - $ as of 2026-07-30
Profile
Gerry Brunk is the founder of Lumira Capital Investment Management, Inc., founded in 2002, serving as Managing Partner since 2020.
Current jobs include Director at enGene, Inc. since 2017; Director at ActivBiotics, Inc.; Director at BAROnova, Inc.; Director at Endotronix, Inc.; Director at HistoSonics, Inc.; Director at Virginia Biotechnology Association since 2022; Director at Corvia Medical, Inc. since 2013; Director at Engage Therapeutics, Inc.; Director at Cyrano Therapeutics, Inc. since 2020; Director at Southeast Life Sciences; President, Secretary & Director at LAVA Medtech Acquisition Corp.
since 2021; and Independent Non-Executive Director at enGene Therapeutics, Inc. since 2023.
Former jobs include Director at AdipoGenix, Inc.; Director at Cardiac Dimensions, Inc.; Director at Pharmasset, Inc.; Director at MAKO Surgical Corp.; Director at Celtaxsys, Inc.; Director at Targanta Therapeutics, Inc.; Member at Credit Suisse (USA) LLC; Chief Operating Officer at ActiveCyte, Inc. from 2000 to 2002; Manager-Health Care Practice at The Boston Consulting Group, Inc. from 1994 to 1999; and Member-Investment Banking Group at Credit Suisse First Boston Corp.
from 1990 to 1992.
Education includes undergraduate degree from the University of Virginia and MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-15 | 0 ( -.--% ) | - $ | 2026-07-30 |
Gerry Brunk active positions
| Companies | Position | Start |
|---|---|---|
| LAVA MEDTECH ACQUISITION CORP. | President | 2021-09-30 |
| ENGENE THERAPEUTICS INC. | Director/Board Member | 2023-08-07 |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Founder | 2002-05-31 |
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Promotes biotechnology industry | Director/Board Member | 2022-03-31 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Director/Board Member | 2017-09-30 |
Southeast Life Sciences
 Southeast Life Sciences Southeast Life Sciences, established in 2019 through the merger of the Southeastern Medical Device Association and Southeast BIO, is a unified platform dedicated to advancing medtech and bioscience innovation, partnering, and investor relations in the southeastern United States. The private company is based in Roswell. The American company cultivates, connects, and convenes the entrepreneurial community to foster innovation and investment for public benefit. It supports investors by providing de-risked opportunities, assists emerging companies by linking them with investors and partners, and helps solution providers find clients. Key initiatives include the annual AdvanSE Life Sciences Conference, women@sls for networking and leadership development for women in life sciences, and SE Color to support minority life science entrepreneurs through increased investment, improved access to clinical trials and vaccinations, and events like pitch competitions. | Director/Board Member | - |
Cyrano Therapeutics, Inc.
 Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops intranasal sprays | Director/Board Member | 2020-11-30 |
HistoSonics, Inc.
 HistoSonics, Inc. Medical SpecialtiesHealth Technology Develops and manufactures non-invasive devices to treat liver tumors | Director/Board Member | - |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Develops rescue therapy for uncontrolled epileptic seizures | Director/Board Member | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Gerry Brunk
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Gerry Brunk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
25
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 25 |
|---|---|
AdipoGenix, Inc.
 AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular pharmaceutical products | Health Technology |
Cardiac Dimensions, Inc.
 Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Develops novel interventional tools for the treatment of heart failures | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
MAKO Surgical Corp.
 MAKO Surgical Corp. Medical SpecialtiesHealth Technology Develops orthopedic medical device | Health Technology |
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases | Health Technology |
Credit Suisse (USA) LLC
 Credit Suisse (USA) LLC Investment Banks/BrokersFinance Provides investment banking and asset management services | Finance |
BAROnova, Inc.
 BAROnova, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage medical-device company | Health Technology |
Endotronix, Inc.
 Endotronix, Inc. Medical SpecialtiesHealth Technology Develops implantable pulmonary artery pressure sensor for heart | Health Technology |
HistoSonics, Inc.
HistoSonics, Inc. Medical SpecialtiesHealth Technology Develops and manufactures non-invasive devices to treat liver tumors | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Credit Suisse First Boston Corp.
 Credit Suisse First Boston Corp. Real Estate Investment TrustsFinance Real Estate Investment Trusts | Finance |
Targanta Therapeutics, Inc.
 Targanta Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotic drugs and other related products | Health Technology |
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Promotes biotechnology industry | Commercial Services |
ActiveCyte, Inc. | |
Corvia Medical, Inc.
 Corvia Medical, Inc. Medical SpecialtiesHealth Technology Develops structural heart devices | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Engage Therapeutics, Inc.
Engage Therapeutics, Inc. BiotechnologyHealth Technology Develops rescue therapy for uncontrolled epileptic seizures | Health Technology |
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops intranasal sprays | Health Technology |
LAVA Medtech Acquisition Corp.
 LAVA Medtech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Southeast Life Sciences
Southeast Life Sciences Southeast Life Sciences, established in 2019 through the merger of the Southeastern Medical Device Association and Southeast BIO, is a unified platform dedicated to advancing medtech and bioscience innovation, partnering, and investor relations in the southeastern United States. The private company is based in Roswell. The American company cultivates, connects, and convenes the entrepreneurial community to foster innovation and investment for public benefit. It supports investors by providing de-risked opportunities, assists emerging companies by linking them with investors and partners, and helps solution providers find clients. Key initiatives include the annual AdvanSE Life Sciences Conference, women@sls for networking and leadership development for women in life sciences, and SE Color to support minority life science entrepreneurs through increased investment, improved access to clinical trials and vaccinations, and events like pitch competitions. | |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Gerry Brunk
